170 related articles for article (PubMed ID: 38503729)
1. Piplartine eliminates CD34 + AML stem/progenitor cells by inducing oxidative stress and suppressing NF-κB signalling.
Rodrigues ACBDC; Silva SLR; Dias IRSB; Costa RGA; Oliveira MS; Soares MBP; Dias RB; Valverde LF; Rocha CAG; Johnson EM; Pina C; Bezerra DP
Cell Death Discov; 2024 Mar; 10(1):147. PubMed ID: 38503729
[TBL] [Abstract][Full Text] [Related]
2. Emetine induces oxidative stress, cell differentiation and NF-κB inhibition, suppressing AML stem/progenitor cells.
Silva SLR; Dias IRSB; Rodrigues ACBDC; Costa RGA; Oliveira MS; Barbosa GADC; Soares MBP; Dias RB; Valverde LF; Rocha CAG; Roy N; Park CY; Bezerra DP
Cell Death Discov; 2024 Apr; 10(1):201. PubMed ID: 38684672
[TBL] [Abstract][Full Text] [Related]
3. Bortezomib suppresses acute myelogenous leukaemia stem-like KG-1a cells via NF-κB inhibition and the induction of oxidative stress.
Costa RGA; Oliveira MS; Rodrigues ACBDC; Silva SLR; Dias IRSB; Soares MBP; de Faro Valverde L; Gurgel Rocha CA; Dias RB; Bezerra DP
J Cell Mol Med; 2024 Apr; 28(8):e18333. PubMed ID: 38652192
[TBL] [Abstract][Full Text] [Related]
4. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
Lu C; Hassan HT
Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
[TBL] [Abstract][Full Text] [Related]
5. Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species.
Jin Y; Lu Z; Ding K; Li J; Du X; Chen C; Sun X; Wu Y; Zhou J; Pan J
Cancer Res; 2010 Mar; 70(6):2516-27. PubMed ID: 20215516
[TBL] [Abstract][Full Text] [Related]
6. Disulfiram/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-κB and Nrf2.
Xu B; Wang S; Li R; Chen K; He L; Deng M; Kannappan V; Zha J; Dong H; Wang W
Cell Death Dis; 2017 May; 8(5):e2797. PubMed ID: 28518151
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis repressor with caspase recruitment domain modulates second mitochondrial-derived activator of caspases mimetic-induced cell death through BIRC2/MAP3K14 signalling in acute myeloid leukaemia.
Mak PY; Mak DH; Ruvolo V; Jacamo R; Kornblau SM; Kantarjian H; Andreeff M; Carter BZ
Br J Haematol; 2014 Nov; 167(3):376-84. PubMed ID: 25079338
[TBL] [Abstract][Full Text] [Related]
8. Liposomal encapsulation of a synergistic molar ratio of cytarabine and daunorubicin enhances selective toxicity for acute myeloid leukemia progenitors as compared to analogous normal hematopoietic cells.
Kim HP; Gerhard B; Harasym TO; Mayer LD; Hogge DE
Exp Hematol; 2011 Jul; 39(7):741-50. PubMed ID: 21530609
[TBL] [Abstract][Full Text] [Related]
9. The NF (Nuclear factor)-κB inhibitor parthenolide interacts with histone deacetylase inhibitors to induce MKK7/JNK1-dependent apoptosis in human acute myeloid leukaemia cells.
Dai Y; Guzman ML; Chen S; Wang L; Yeung SK; Pei XY; Dent P; Jordan CT; Grant S
Br J Haematol; 2010 Oct; 151(1):70-83. PubMed ID: 20701602
[TBL] [Abstract][Full Text] [Related]
10. NF-kappaB inhibition sensitizes to starvation-induced cell death in high-risk myelodysplastic syndrome and acute myeloid leukemia.
Fabre C; Carvalho G; Tasdemir E; Braun T; Adès L; Grosjean J; Boehrer S; Métivier D; Souquère S; Pierron G; Fenaux P; Kroemer G
Oncogene; 2007 Jun; 26(28):4071-83. PubMed ID: 17213804
[TBL] [Abstract][Full Text] [Related]
11. Novel piplartine-containing ruthenium complexes: synthesis, cell growth inhibition, apoptosis induction and ROS production on HCT116 cells.
D'Sousa Costa CO; Araujo Neto JH; Baliza IRS; Dias RB; Valverde LF; Vidal MTA; Sales CBS; Rocha CAG; Moreira DRM; Soares MBP; Batista AA; Bezerra DP
Oncotarget; 2017 Nov; 8(61):104367-104392. PubMed ID: 29262647
[TBL] [Abstract][Full Text] [Related]
12. Artesunate, a new antimalarial clinical drug, exhibits potent anti-AML activity by targeting the ROS/Bim and TFRC/Fe
Liu Y; Li H; Luo Z; Yu Y; Yang J; Zhang M; Law BYK; Huang Z; Li W
Br J Pharmacol; 2023 Mar; 180(6):701-720. PubMed ID: 36368726
[TBL] [Abstract][Full Text] [Related]
13. Protection of acute myeloid leukaemia cells from apoptosis induced by front-line chemotherapeutics is mediated by haem oxygenase-1.
Heasman SA; Zaitseva L; Bowles KM; Rushworth SA; Macewan DJ
Oncotarget; 2011 Sep; 2(9):658-68. PubMed ID: 21911919
[TBL] [Abstract][Full Text] [Related]
14. Smac mimetic primes apoptosis-resistant acute myeloid leukaemia cells for cytarabine-induced cell death by triggering necroptosis.
Chromik J; Safferthal C; Serve H; Fulda S
Cancer Lett; 2014 Mar; 344(1):101-109. PubMed ID: 24184825
[TBL] [Abstract][Full Text] [Related]
15. Bortezomib interacts synergistically with belinostat in human acute myeloid leukaemia and acute lymphoblastic leukaemia cells in association with perturbations in NF-κB and Bim.
Dai Y; Chen S; Wang L; Pei XY; Kramer LB; Dent P; Grant S
Br J Haematol; 2011 Apr; 153(2):222-35. PubMed ID: 21375523
[TBL] [Abstract][Full Text] [Related]
16. Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AML.
Herrmann H; Blatt K; Shi J; Gleixner KV; Cerny-Reiterer S; Müllauer L; Vakoc CR; Sperr WR; Horny HP; Bradner JE; Zuber J; Valent P
Oncotarget; 2012 Dec; 3(12):1588-99. PubMed ID: 23249862
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal COX2-PG secretome engages NR4A-WNT signalling axis in haematopoietic progenitors to suppress anti-leukaemia immunity.
Wu L; Amarachintha S; Xu J; Oley F; Du W
Br J Haematol; 2018 Nov; 183(3):445-456. PubMed ID: 30106181
[TBL] [Abstract][Full Text] [Related]
18. (-)-Epigallocatechin-3-gallate induces apoptosis and differentiation in leukaemia by targeting reactive oxygen species and PIN1.
Della Via FI; Shiraishi RN; Santos I; Ferro KP; Salazar-Terreros MJ; Franchi Junior GC; Rego EM; Saad STO; Torello CO
Sci Rep; 2021 Apr; 11(1):9103. PubMed ID: 33907248
[TBL] [Abstract][Full Text] [Related]
19. Divergent effect of taxol on proliferation, apoptosis and nitric oxide production in MHH225 CD34 positive and U937 CD34 negative human leukaemia cells.
Al-alami O; Sammons J; Martin JH; Hassan HT
Leuk Res; 1998 Oct; 22(10):939-45. PubMed ID: 9766754
[TBL] [Abstract][Full Text] [Related]
20. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
